23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...
DNA-testing site 23andMe to lay off 40% of its workers
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
FierceBiotech7h
23andMe shutters cancer drug research programs, lays off 40% of staff
Prior to that, 23andMe’s independent directors—Roelof Botha, Patrick Chung, Sandra Hernández, Neal Mohan, Valerie Montgomery ...
manilatimes4d
CTS Corporation Declares a Dividend
LISLE, Ill., Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE: CTS) has declared a cash ...
Nila Bala: The risks of sharing your DNA with online companies aren’t a future concern. They’re here now
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...
cfodive11d
23andMe turns to CFOs to fill director roles after mass board exit
Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...
23andMe has three new directors—after the previous board all resigned
Me appoints three former CFOs as new directors—after the previous board all resigned.
23andMe appoints three former CFOs as new directors—after the previous board all resigned
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
23andMe appoints new board members as it works to stem the company's slide
Me has appointed three new independent directors to its board.